Rhumbline Advisers »

Seres Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $193k 138k 1.40
2023-09-30 $325k 137k 2.38
2023-06-30 $646k 135k 4.79
2023-03-31 $535k 94k 5.67
2022-12-31 $502k 90k 5.60
2022-09-30 $564k 88k 6.41
2022-06-30 $269k 79k 3.43
2022-03-31 $588k 83k 7.12
2021-12-31 $689k 83k 8.33
2021-09-30 $568k 82k 6.96
2021-06-30 $1.9M 79k 23.86
2021-03-31 $1.5M 71k 20.59
2020-12-31 $1.9M 76k 24.50
2020-09-30 $1.9M 66k 28.32
2020-06-30 $267k 56k 4.76
2020-03-31 $164k 46k 3.57
2019-12-31 $158k 46k 3.44
2019-09-30 $170k 42k 4.01
2019-06-30 $119k 37k 3.23
2019-03-31 $185k 27k 6.88
2018-12-31 $123k 27k 4.53
2018-09-30 $138k 18k 7.57
2018-06-30 $168k 20k 8.59
2018-03-31 $137k 19k 7.32
2017-12-31 $194k 19k 10.16
2017-09-30 $365k 23k 16.03
2017-06-30 $254k 23k 11.30
2017-03-31 $221k 20k 11.29
2016-12-31 $188k 19k 9.89
2016-09-30 $193k 16k 12.27
2016-06-30 $448k 15k 29.03
2016-03-31 $220k 8.3k 26.62
2015-12-31 $271k 7.7k 35.08